Protocol Summaries: GSK1160724
| GSK Study ID |
Phase | Title | Status |
|---|---|---|---|
| AC5108696 | Phase 1 | A randomized double-blind, placebo-controlled, crossover, dose escalation study to examine the safety, tolerability, pharmacodynamics and pharmacokinetics of single inhaled doses of GSK1160724 and tiotropium bromide | Completed |